REGULATED CRYPTO EXCHANGE
Русский
Español
Emergent BioSolutions
Sell20.28
Spread0.15
Buy20.43

Trade Emergent BioSolutions Inc. - EBS stock price

Sell20.28
Spread0.15
Buy20.43
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). Its products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. The company offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. It also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, the company offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, it offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, the company offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. Emergent BioSolutions Inc. has a development and manufacturing agreement with Novavax Inc. for coronavirus disease vaccine candidate. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play Explore platform Show QR
Articles
Seneca Protocol experiences $6m breach, SEN drops 65% 
Read more
Aptos surges 18%, development activity reaches 2-month high
Read more
Solana climbs 13% to hit new yearly high, sparked by Dogwifhat memecoin momentum
Read more
Jeeves eyes Middle East launch by 2025, CEO hints at Web Summit Qatar 2024
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

EBS price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 20.28 -0.47 -2.27 20.75 20.26 20.78
2022-09-30 21.3 0.51 2.45 20.79 20.45 21.51
2022-09-30 20.45 0.10 0.49 20.35 20.16 20.68
2022-09-30 20.02 -0.61 -2.96 20.63 20.0 21.27
2022-09-30 20.78 0.13 0.63 20.65 20.26 20.92
2022-09-30 21.04 0.11 0.53 20.93 20.69 21.29
2022-09-30 21.29 -0.27 -1.25 21.56 21.24 22.3
2022-09-30 21.7 -0.26 -1.18 21.96 21.6 22.27
2022-09-30 22.4 -0.04 -0.18 22.44 21.75 22.55
2022-09-30 22.84 0.37 1.65 22.47 22.37 23.3
2022-09-30 22.98 0.58 2.59 22.4 22.3 23.33
2022-09-30 22.62 -0.09 -0.40 22.71 22.2 23.2
2022-09-30 22.76 -1.36 -5.64 24.12 22.59 24.27
2022-09-30 25.0 -0.01 -0.04 25.01 24.6 25.42
2022-09-30 25.0 2.09 9.12 22.91 22.57 25.12
2022-09-30 22.92 0.65 2.92 22.27 22.2 23.03
2022-09-30 22.66 0.61 2.77 22.05 21.82 22.76
2022-09-30 22.25 -0.39 -1.72 22.64 21.77 22.72
2022-09-30 22.92 -0.64 -2.72 23.56 22.78 24.01
2022-09-30 23.64 0.14 0.60 23.5 22.78 23.64
Go help.dzengi.com